CPT1A缓解衰老,并通过SOD2顺化恢复BM-MSC的骨质分化
Xiao Yuan Wang1, Shi Chang Liu2, Xu Xu Chen3
1Physical Examination Center, Xi'an International Medical Center Hospital, Xi'an, China.
Journal of cellular and molecular medicine
|March 12, 2025
概括
卡尼丁棕基转移酶1A (CPT1A) 影响骨髓中酶干细胞 (BM-MSC) 衰老和骨修复. CPT1A增强了超氧化物脱酶2 (SOD2) 糖化,增强了线粒体SOD2活性,以减少衰老和促进骨质分化.
科学领域:
- 生物医学工程 生物医学工程
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 骨髓介质干细胞 (BM-MSCs) 对于骨修复至关重要,但随着细胞的传递而失去功能.
- 了解BM-MSC衰老的机制对于再生医学应用至关重要.
研究的目的:
- 研究卡尼丁棕基转移酶1A (CPT1A) 在BM-MSC衰老和骨质分化中的作用.
- 阐明CPT1A与BM-MSC衰老相关的分子机制.
主要方法:
- 西方涂抹和SA-β-gal染色用于衰老.
- 阿利扎林红色染色用于骨质分化.
- 对线粒体ROS的流细胞计.
- 共同免疫沉 (Co-IP) 测定蛋白质相互作用和化.
主要成果:
- 随着BM-MSC传递,CPT1A的表达减少,与减少的增殖和骨质生成能力相关.
- CPT1A的敲击增加了线粒体ROS,并降低了超氧化物异位酶2 (SOD2) 的活性.
- CPT1A过度表达逆转了这些影响,减少衰老并增强分化.
- CPT1A在K130促进了SOD2化,增加了线粒体SOD2水平和活性.
结论:
- CPT1A水平与BM-MSC衰老表型和骨质生成差异化潜力直接相关.
- 在K130中通过CPT1A介导的SOD2化是缓解BM-MSC衰老的关键机制.
- 向CPT1A可能提供一种治疗策略,以增强骨再生中的BM-MSC功能.
更多相关视频
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K


